Posted inLondon Stock Exchange
Biotech firm Evommune raises $150 million in initial public offering
LONDON: RTW Biotech Opportunities Ltd., a London-listed investment company, announced Wednesday that its portfolio company, Evommune Inc., has completed a $150 million initial public offering on the New York Stock…